ArticleFrontiers in immunology2026
Gestational benzene exposure programs sex-specific neuroimmune responses to postnatal viral infection.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Background: Benzene is a widespread volatile organic compound, but its effects on fetal neuroimmune development remain poorly defined. We tested whether continuous gestational benzene exposure alters fetal placenta-brain signaling, fetal brain myeloid phenotype, and selected postnatal responses to viral challenge. Methods: Pregnant C57BL/6 mice were exposed to filtered air or 5 ppm benzene continuously from E0.5 to E12.5 or E17.5. Fetal tissues were collected at the respective endpoints. A separate cohort exposed through E17.5 delivered naturally; offspring received MHV68 at PND10 and were analyzed at PND17. We assessed fetal morphometry, sex-stratified transcriptomic and qPCR profiles, and brain myeloid-cell phenotypes. Results: Benzene exposure was associated with a female-specific reduction in occipitofrontal diameter at E12.5 that was not detected at E17.5. Transcriptomic and qPCR analyses identified sex-dependent differences at the two fetal collection endpoints in developmental, immune, and GPCR-linked signaling pathways. At E17.5, benzene exposure reduced EGR2 and increased MHC II in fetal brain myeloid/microglia-enriched cells in both sexes. At PND17 after MHV68 challenge, prenatally exposed males had higher brain ORF65 and Conclusions: Continuous gestational benzene exposure was associated with sex-dependent alterations in fetal neuroimmune measures and selected postnatal responses to viral challenge. Because the E12.5 and E17.5 cohorts differed in developmental age, cumulative exposure duration, and neural tissue collected (fetal head versus fetal brain), the study does not identify a discrete gestational window of susceptibility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.